510(k) K061492

MONOJECT MAGELLAN INSULIN AND TUBERCULIN SAFETY SYRINGE by Tyco Healthcare — Product Code FMF

K061492 is an FDA 510(k) premarket notification submitted by Tyco Healthcare for the device "MONOJECT MAGELLAN INSULIN AND TUBERCULIN SAFETY SYRINGE". The FDA issued a decision of Substantially Equivalent on August 3, 2006. The device falls under product code FMF (Syringe, Piston), a Class II device regulated under 21 CFR 880.5860. Tyco Healthcare has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 3, 2006
Date Received
May 31, 2006
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Syringe, Piston
Device Class
Class II
Regulation Number
880.5860
Review Panel
HO
Submission Type